These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction. Been M; de Bono DP; Muir AL; Boulton FE; Fears R; Standring R; Ferres H Int J Cardiol; 1986 Apr; 11(1):53-61. PubMed ID: 3514485 [TBL] [Abstract][Full Text] [Related]
69. Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. de Swart JB Drugs; 1987; 33 Suppl 3():279-81. PubMed ID: 3315607 [No Abstract] [Full Text] [Related]
70. The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction. Hillis WS; Hornung RS Eur Heart J; 1985 Nov; 6(11):909-12. PubMed ID: 3908105 [No Abstract] [Full Text] [Related]
71. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Ikram S; Lewis S; Bucknall C; Sram I; Thomas N; Vincent R; Chamberlain D Br Med J (Clin Res Ed); 1986 Sep; 293(6550):786-9. PubMed ID: 3094657 [TBL] [Abstract][Full Text] [Related]
72. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery. Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932 [TBL] [Abstract][Full Text] [Related]
73. [Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction]. Bassand JP; Cassagnes J; Machecourt J; Anguenot T; Lusson JR; Borel E; Schiele F; Wolf JF; Vachet D Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():31-6. PubMed ID: 2108644 [TBL] [Abstract][Full Text] [Related]
74. [Fibrinolysis therapy using APSAC in acute myocardial infarct]. Hochrein H Dtsch Med Wochenschr; 1990 Jun; 115(25):999. PubMed ID: 2193790 [No Abstract] [Full Text] [Related]
75. A symposium: Early intervention in the treatment of acute myocardial infarction--clinical profile of Eminase (APSAC). November 12, 1988, Washington, D.C. Am J Cardiol; 1989 Jul; 64(2):1A-42A. PubMed ID: 2662736 [No Abstract] [Full Text] [Related]
78. Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction. French JK; Straznicky IT; Webber BJ; Aylward PE; Frey MJ; Adgey AA; Williams BF; McLaughlin SC; White HD Heart; 1999 Feb; 81(2):128-33. PubMed ID: 9922346 [TBL] [Abstract][Full Text] [Related]
79. Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction. Kasper W; Erbel R; Meinertz T; Drexler M; Rückel A; Pop T; Prellwitz W; Meyer J J Am Coll Cardiol; 1984 Aug; 4(2):357-63. PubMed ID: 6429226 [TBL] [Abstract][Full Text] [Related]
80. Prehospital use of APSAC: results of a placebo-controlled study. Castaigne AD; Hervé C; Duval-Moulin AM; Gaillard M; Dubois-Rande JL; Boesch C; Wolf M; Lellouche D; Jan F; Vernant P Am J Cardiol; 1989 Jul; 64(2):30A-33A; discussion 41A-42A. PubMed ID: 2662741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]